{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:17:37Z","timestamp":1793999857455,"version":"4.8.0"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.18632\/aging.102982","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T04:14:01Z","timestamp":1585887241000},"page":"5858-5877","source":"Crossref","is-referenced-by-count":10,"title":["Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes"],"prefix":"10.18632","volume":"12","author":[{"given":"Mengqing","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xu Zhou Medical University Hospital, Xuzhou 221000, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Shu Yang Hospital, Nanjing University of Traditional Chinese Medicine, Shuyang 223600, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Shu Yang Hospital, Nanjing University of Traditional Chinese Medicine, Shuyang 223600, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihe","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.","volume":"12","author":"Roy","year":"2014","journal-title":"Circulation"},{"key":"2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.","volume":"38","author":"St\u00e5hle","year":"2013","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10557-015-6618-1","article-title":"Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: data from the GIPS-III Trial.","volume":"2","author":"van der Horst","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"4","doi-asserted-by":"publisher","first-page":"5K","DOI":"10.1016\/j.amjcard.2006.01.019","article-title":"Epidemiology and prognostic implications of contrast-induced nephropathy.","volume":"9","author":"Tumlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1540-8183.2007.00318.x","article-title":"Contrast-induced nephropathy.","volume":"2","author":"Marenzi","year":"2008","journal-title":"J Interv Cardiol"},{"key":"6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/2277-9175.180638","article-title":"Ascorbic acid effect on CIN incidence in diabetic patient after coronary angiography.","volume":"5","author":"Namayandeh","year":"2016","journal-title":"Adv Biomed Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0168-8227(09)70012-9","article-title":"Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: risk-factors and prognostic value.","volume":"8","author":"Dedov","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/83.10.1095","article-title":"Mortality associated with nephropathy after radiographic contrast exposure.","volume":"8","author":"McDonald","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.04.002","article-title":"Impact of kinins in the treatment of cardiovascular diseases.","volume":"13","author":"Gobeil","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2337\/diacare.28.9.2261","article-title":"The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes.","volume":"2","author":"Coleman","year":"2005","journal-title":"Diabetes Care"},{"key":"11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"7","author":"Ovbiagele","year":"2018","journal-title":"Hypertension"},{"key":"12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0140-6736(07)61035-6","article-title":"Renin-angiotensin system and cardiovascular risk.","volume":"37","author":"Pezzetta","year":"2007","journal-title":"Lancet"},{"key":"13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.","volume":"38","author":"Strippoli","year":"2015","journal-title":"Lancet"},{"key":"14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3109\/0886022X.2013.766566","article-title":"The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.","volume":"3","author":"Tokgoz","year":"2013","journal-title":"Ren Fail"},{"key":"15","doi-asserted-by":"publisher","first-page":"e0129747","DOI":"10.1371\/journal.pone.0129747","article-title":"The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis.","volume":"1","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","article-title":"Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.","volume":"9","author":"Mehran","year":"2005","journal-title":"Am J Cardiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ahj.2015.04.019","article-title":"Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.","volume":"17","author":"Mehta","year":"2015","journal-title":"Am Heart J"},{"key":"18","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.","volume":"2","author":"Heinz-Peer","year":"2011","journal-title":"Eur Radiol"},{"key":"19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1053\/j.ajkd.2012.04.017","article-title":"The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.","volume":"6","author":"Jung","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3904\/kjim.2014.29.2.203","article-title":"Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.","volume":"2","author":"Kim","year":"2014","journal-title":"Korean J Intern Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/ndt\/gfp582","article-title":"Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.","volume":"2","author":"Reinecke","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ndt\/gfl636","article-title":"Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.","volume":"2","author":"Esi","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"23","doi-asserted-by":"publisher","first-page":"c20","DOI":"10.1159\/000093255","article-title":"Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.","volume":"10","author":"Esi","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"24","first-page":"2895","article-title":"Paricalcitol counteracts the increased contrast induced nephropathy caused by renin-angiotensin-aldosterone system blockade therapy in a rat model.","volume":"1","author":"Dinckal","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"25","first-page":"521","article-title":"Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.","volume":"5","author":"Sharma","year":"1999","journal-title":"Indian Heart J"},{"key":"26","doi-asserted-by":"publisher","first-page":"1470320317708894","DOI":"10.1177\/1470320317708894","article-title":"Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.","volume":"1","author":"Chen","year":"2017","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"27","first-page":"432","article-title":"Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.","volume":"6","author":"Ghahramani","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11255-008-9368-1","article-title":"The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.","volume":"4","author":"Michelis","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2011.06.115","article-title":"Pathophysiology of contrast-induced nephropathy.","volume":"15","author":"Zhang","year":"2012","journal-title":"Int J Cardiol"},{"key":"30","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1097\/CCM.0b013e318168cdc3","article-title":"Acute kidney injury with iodinated contrast.","volume":"3","author":"McCullough","year":"2008","journal-title":"Crit Care Med"},{"key":"31","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: mechanisms, risk factors, and prevention.","volume":"3","author":"Persson","year":"2012","journal-title":"Eur Heart J"},{"key":"32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0735-1097(99)00168-0","article-title":"Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.","volume":"3","author":"Yasue","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.","volume":"29","author":"Colette","year":"2006","journal-title":"JAMA"},{"key":"34","doi-asserted-by":"publisher","first-page":"e008122","DOI":"10.1161\/JAHA.117.008122","article-title":"Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia.","volume":"7","author":"Assanelli","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy.","volume":"6","author":"Liss","year":"2005","journal-title":"Kidney Int"},{"key":"36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1152\/physiol.00003.2005","article-title":"New fACEs to the renin-angiotensin system.","volume":"2","author":"Busse","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/hc3801.095585","article-title":"Are ACE inhibitors a \u201cmagic bullet\u201d against oxidative stress?","volume":"10","author":"Keaney","year":"2001","journal-title":"Circulation"},{"key":"38","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/hc4101.096153","article-title":"Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.","volume":"10","author":"Wilcox","year":"2001","journal-title":"Circulation"},{"key":"39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.5301\/jn.5000059","article-title":"ACE inhibitor or angiotensin II receptor blocker use is a risk factor for contrast-induced nephropathy.","volume":"2","author":"Superdock","year":"2012","journal-title":"J Nephrol"},{"key":"40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000105124","article-title":"TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis.","volume":"2","author":"Emala","year":"2007","journal-title":"Am J Nephrol"},{"key":"41","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.V8111732","article-title":"Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney.","volume":"8","author":"Hostetter","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"42","doi-asserted-by":"publisher","first-page":"423848","DOI":"10.1155\/2014\/423848","article-title":"ACE-I\/ARB therapy prior to contrast exposure: what should the clinician do?","volume":"201","author":"Perazella","year":"2014","journal-title":"Biomed Res Int"},{"key":"43","first-page":"333","article-title":"Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings?","volume":"2","author":"Garovic","year":"2009","journal-title":"J Nephrol"},{"key":"44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7326\/0003-4819-110-2-119","article-title":"Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.","volume":"11","author":"Bashore","year":"1989","journal-title":"Ann Intern Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1681\/ASN.2016020154","article-title":"The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging.","volume":"2","author":"Rule","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jacc.2004.06.068","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.","volume":"4","author":"Dangas","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00380-016-0836-8","article-title":"Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.","volume":"3","author":"Kimura","year":"2017","journal-title":"Heart Vessels"},{"key":"48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0003319712463816","article-title":"Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.","volume":"6","author":"\u00c7ayli","year":"2014","journal-title":"Angiology"},{"key":"49","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3109\/0886022X.2011.653753","article-title":"New insights into uric acid effects on the progression and prognosis of chronic kidney disease.","volume":"3","author":"Vlassopoulos","year":"2012","journal-title":"Ren Fail"},{"key":"50","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1253\/circj.CJ-15-0556","article-title":"Why Is Proteinuria an Independent Risk Factor for Contrast-Induced Nephropathy?","volume":"7","author":"Yoshihara","year":"2015","journal-title":"Circ J"},{"key":"51","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/ndt\/gfh1070","article-title":"How to avoid CIN: guidelines from the European Society of Urogenital Radiology.","volume":"2","author":"Thomsen","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","article-title":"Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.","volume":"3","author":"Ly","year":"2016","journal-title":"Can J Cardiol"},{"key":"53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2016.196","article-title":"Understanding and preventing contrast-induced acute kidney injury.","volume":"1","author":"Persson","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.numecd.2014.08.008","article-title":"Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.","volume":"2","author":"De Luca","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"55","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.","volume":"1","author":"Levin","year":"2007","journal-title":"Crit Care"},{"key":"56","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus.","volume":"2","author":"Rizza","year":"2003","journal-title":"Diabetes Care"},{"key":"57","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension.","volume":"3","author":"Redon","year":"2018","journal-title":"Eur Heart J"},{"key":"58","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"3","author":"Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.ajkd.2010.03.026","article-title":"Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL\/min\/1.73 m2.","volume":"5","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T12:29:41Z","timestamp":1666268981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,4,15]]}},"alternative-id":["102982","32241961"],"URL":"https:\/\/doi.org\/10.18632\/aging.102982","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}